Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2111377 Target Snapshot

CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) · PROTEIN COMPLEX · Homo sapiens

349Compounds
98Assays
0Approved Drugs
398.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9UBU7. Use UniProt Q9UBU7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9UBU7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) as ChEMBL target CHEMBL2111377, mapped to UniProt Q9UBU7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase)
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2111377
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9UBU7
Protein DBF4 homolog A
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) is the right protein anchor across sources, using UniProt Q9UBU7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProtein DBF4 homolog A
UniProt AccessionQ9UBU7
Component TypeProtein
Sequence Length674 aa

Protein DBF4 homolog A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase), mapped to UniProt Q9UBU7. ChEMBL maps the protein component as Protein DBF4 homolog A. Sequence length is 674 aa.

Mapped IDQ9UBU7
Review nameCDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase)
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC50342.0
KI39.0
EC5012.0
KD5.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1958411 10.05 Ki 0.09 Preclinical
CHEMBL1958417 9.96 Ki 0.11 Preclinical
CHEMBL1958412 9.92 Ki 0.12 Preclinical
CHEMBL1958416 9.85 Ki 0.14 Preclinical
CHEMBL4436649 9.8 IC50 0.16 Preclinical
CHEMBL4462898 9.8 IC50 0.16 Preclinical
CHEMBL1958414 9.74 Ki 0.18 Preclinical
CHEMBL1958415 9.74 Ki 0.18 Preclinical
CHEMBL1958419 9.7 Ki 0.2 Preclinical
CHEMBL1958420 9.7 Ki 0.2 Preclinical
Distribution

pChEMBL Value Distribution

16
5.0
21
5.5
38
6.0
50
6.5
34
7.0
35
7.5
46
8.0
40
8.5
25
9.0
12
9.5
pChEMBL
Assay Landscape

Assay Landscape

98
Total Assays
271
Tested Compounds
1
Assay Types
Binding — 98 assays, 271 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 68 97 6.9
assay format 22 115 8.2
cell-based format 8 59 6.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine